News & Insights

Press Releases
Article
09.10.2026
Prime Therapeutics names Manmohan Mahajan chief financial officer

Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and financial services organizations

Article
10.01.2025
Prime Therapeutics Scales Judi® Platform Implementations with Support from PwC

Accelerated platform deployment meets rising demand for pharmacy innovation 

Article, Awards
03.31.2025
Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

Prime to present seven studies and receive the 2024 JMCP Award for Excellence

Article
04.11.2024
Prime Therapeutics and Magellan Rx to present eight managed care pharmacy research studies at AMCP

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

Article
06.19.2024
Prime/MRx’s new Advocate+™ Pharmacy Match technology-driven solution expands specialty pharmacy access and choice

Using real-time pricing, Advocate+ Pharmacy Match drives affordability for plan sponsors while offering access to the most competitive pharmacy for each member.

Article, Awards
10.16.2023
Prime Therapeutics and Magellan Rx to present three managed care pharmacy research studies at AMCP Nexus

Identifying and managing diabetes and weight loss therapies earns AMCP platinum award

Article
10.12.2023
Prime/Magellan Rx launch industry-leading Medical Pharmacy Trend Report™

13th annual report the preeminent source for medical benefit drug trend

Article
09.18.2023
Prime Therapeutics and Magellan Rx enhance specialty pharmacy patient experience with Inovalon’s ScriptMed® SaaS Solution

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

Article
08.24.2023
Magellan Rx Management releases new report, “The State of Value-based Contracting (VBC): Reinventing the Current Drug Payment Model in Medicaid”

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Article
07.12.2023
Prime Therapeutics sets forth new formulary recommendations to increase affordability with several new Humira® biosimilars

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

Article, Awards
03.16.2023
Prime Therapeutics and Magellan Rx to present seven managed care pharmacy research studies at AMCP conference

Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.

Article
01.05.2023
Magellan Rx Management issues seventh Medicaid Pharmacy Trend Report™

Report features new highlights and rankings of the top 50 drug classes by percent of net spend.

Showing 1 to 12 of 44